The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Live Attenuated Vaccines for Pets Market Research Report 2025
Synopsis
Live attenuated vaccines are vaccines made from killed pathogens.
The global Live Attenuated Vaccines for Pets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 378%.
This report aims to provide a comprehensive presentation of the global market for Live Attenuated Vaccines for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Vaccines for Pets.
Report Scope
The Live Attenuated Vaccines for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Live Attenuated Vaccines for Pets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Attenuated Vaccines for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Segment by Type
Virus Attenuated Vaccine
Bacterial Attenuated Vaccine
Segment by Application
Dog
Cat
Dird
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live Attenuated Vaccines for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live Attenuated Vaccines for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Live attenuated vaccines are vaccines made from killed pathogens.
The global Live Attenuated Vaccines for Pets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 378%.
This report aims to provide a comprehensive presentation of the global market for Live Attenuated Vaccines for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Vaccines for Pets.
Report Scope
The Live Attenuated Vaccines for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Live Attenuated Vaccines for Pets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Attenuated Vaccines for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer
Segment by Type
Virus Attenuated Vaccine
Bacterial Attenuated Vaccine
Segment by Application
Dog
Cat
Dird
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live Attenuated Vaccines for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live Attenuated Vaccines for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Live Attenuated Vaccines for Pets Market Overview
1.1 Product Overview and Scope of Live Attenuated Vaccines for Pets
1.2 Live Attenuated Vaccines for Pets Segment by Type
1.2.1 Global Live Attenuated Vaccines for Pets Market Value Comparison by Type (2024-2030)
1.2.2 Virus Attenuated Vaccine
1.2.3 Bacterial Attenuated Vaccine
1.3 Live Attenuated Vaccines for Pets Segment by Application
1.3.1 Global Live Attenuated Vaccines for Pets Market Value by Application: (2024-2030)
1.3.2 Dog
1.3.3 Cat
1.3.4 Dird
1.3.5 Others
1.4 Global Live Attenuated Vaccines for Pets Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Vaccines for Pets Revenue 2019-2030
1.4.2 Global Live Attenuated Vaccines for Pets Sales 2019-2030
1.4.3 Global Live Attenuated Vaccines for Pets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Live Attenuated Vaccines for Pets Market Competition by Manufacturers
2.1 Global Live Attenuated Vaccines for Pets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Live Attenuated Vaccines for Pets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Live Attenuated Vaccines for Pets Average Price by Manufacturers (2019-2024)
2.4 Global Live Attenuated Vaccines for Pets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Attenuated Vaccines for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Attenuated Vaccines for Pets, Product Type & Application
2.7 Live Attenuated Vaccines for Pets Market Competitive Situation and Trends
2.7.1 Live Attenuated Vaccines for Pets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Live Attenuated Vaccines for Pets Players Market Share by Revenue
2.7.3 Global Live Attenuated Vaccines for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Live Attenuated Vaccines for Pets Retrospective Market Scenario by Region
3.1 Global Live Attenuated Vaccines for Pets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Live Attenuated Vaccines for Pets Global Live Attenuated Vaccines for Pets Sales by Region: 2019-2030
3.2.1 Global Live Attenuated Vaccines for Pets Sales by Region: 2019-2024
3.2.2 Global Live Attenuated Vaccines for Pets Sales by Region: 2025-2030
3.3 Global Live Attenuated Vaccines for Pets Global Live Attenuated Vaccines for Pets Revenue by Region: 2019-2030
3.3.1 Global Live Attenuated Vaccines for Pets Revenue by Region: 2019-2024
3.3.2 Global Live Attenuated Vaccines for Pets Revenue by Region: 2025-2030
3.4 North America Live Attenuated Vaccines for Pets Market Facts & Figures by Country
3.4.1 North America Live Attenuated Vaccines for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Live Attenuated Vaccines for Pets Sales by Country (2019-2030)
3.4.3 North America Live Attenuated Vaccines for Pets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Attenuated Vaccines for Pets Market Facts & Figures by Country
3.5.1 Europe Live Attenuated Vaccines for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Live Attenuated Vaccines for Pets Sales by Country (2019-2030)
3.5.3 Europe Live Attenuated Vaccines for Pets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Attenuated Vaccines for Pets Market Facts & Figures by Country
3.6.1 Asia Pacific Live Attenuated Vaccines for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Live Attenuated Vaccines for Pets Sales by Country (2019-2030)
3.6.3 Asia Pacific Live Attenuated Vaccines for Pets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Live Attenuated Vaccines for Pets Market Facts & Figures by Country
3.7.1 Latin America Live Attenuated Vaccines for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Live Attenuated Vaccines for Pets Sales by Country (2019-2030)
3.7.3 Latin America Live Attenuated Vaccines for Pets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live Attenuated Vaccines for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Attenuated Vaccines for Pets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Live Attenuated Vaccines for Pets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Live Attenuated Vaccines for Pets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Attenuated Vaccines for Pets Sales by Type (2019-2030)
4.1.1 Global Live Attenuated Vaccines for Pets Sales by Type (2019-2024)
4.1.2 Global Live Attenuated Vaccines for Pets Sales by Type (2025-2030)
4.1.3 Global Live Attenuated Vaccines for Pets Sales Market Share by Type (2019-2030)
4.2 Global Live Attenuated Vaccines for Pets Revenue by Type (2019-2030)
4.2.1 Global Live Attenuated Vaccines for Pets Revenue by Type (2019-2024)
4.2.2 Global Live Attenuated Vaccines for Pets Revenue by Type (2025-2030)
4.2.3 Global Live Attenuated Vaccines for Pets Revenue Market Share by Type (2019-2030)
4.3 Global Live Attenuated Vaccines for Pets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Live Attenuated Vaccines for Pets Sales by Application (2019-2030)
5.1.1 Global Live Attenuated Vaccines for Pets Sales by Application (2019-2024)
5.1.2 Global Live Attenuated Vaccines for Pets Sales by Application (2025-2030)
5.1.3 Global Live Attenuated Vaccines for Pets Sales Market Share by Application (2019-2030)
5.2 Global Live Attenuated Vaccines for Pets Revenue by Application (2019-2030)
5.2.1 Global Live Attenuated Vaccines for Pets Revenue by Application (2019-2024)
5.2.2 Global Live Attenuated Vaccines for Pets Revenue by Application (2025-2030)
5.2.3 Global Live Attenuated Vaccines for Pets Revenue Market Share by Application (2019-2030)
5.3 Global Live Attenuated Vaccines for Pets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare Live Attenuated Vaccines for Pets Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Vetoquinol S.A
6.2.1 Vetoquinol S.A Corporation Information
6.2.2 Vetoquinol S.A Description and Business Overview
6.2.3 Vetoquinol S.A Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vetoquinol S.A Live Attenuated Vaccines for Pets Product Portfolio
6.2.5 Vetoquinol S.A Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Live Attenuated Vaccines for Pets Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Live Attenuated Vaccines for Pets Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly Live Attenuated Vaccines for Pets Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Heska
6.6.1 Heska Corporation Information
6.6.2 Heska Description and Business Overview
6.6.3 Heska Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heska Live Attenuated Vaccines for Pets Product Portfolio
6.6.5 Heska Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Live Attenuated Vaccines for Pets Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Merial (Sanofi)
6.8.1 Merial (Sanofi) Corporation Information
6.8.2 Merial (Sanofi) Description and Business Overview
6.8.3 Merial (Sanofi) Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merial (Sanofi) Live Attenuated Vaccines for Pets Product Portfolio
6.8.5 Merial (Sanofi) Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Corporation Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Virbac Live Attenuated Vaccines for Pets Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Live Attenuated Vaccines for Pets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Live Attenuated Vaccines for Pets Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Attenuated Vaccines for Pets Industry Chain Analysis
7.2 Live Attenuated Vaccines for Pets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Attenuated Vaccines for Pets Production Mode & Process
7.4 Live Attenuated Vaccines for Pets Sales and Marketing
7.4.1 Live Attenuated Vaccines for Pets Sales Channels
7.4.2 Live Attenuated Vaccines for Pets Distributors
7.5 Live Attenuated Vaccines for Pets Customers
8 Live Attenuated Vaccines for Pets Market Dynamics
8.1 Live Attenuated Vaccines for Pets Industry Trends
8.2 Live Attenuated Vaccines for Pets Market Drivers
8.3 Live Attenuated Vaccines for Pets Market Challenges
8.4 Live Attenuated Vaccines for Pets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Live Attenuated Vaccines for Pets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Live Attenuated Vaccines for Pets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Live Attenuated Vaccines for Pets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Live Attenuated Vaccines for Pets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Live Attenuated Vaccines for Pets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Live Attenuated Vaccines for Pets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Live Attenuated Vaccines for Pets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Live Attenuated Vaccines for Pets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Live Attenuated Vaccines for Pets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Live Attenuated Vaccines for Pets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Live Attenuated Vaccines for Pets, Product Type & Application
Table 12. Global Key Manufacturers of Live Attenuated Vaccines for Pets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Live Attenuated Vaccines for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccines for Pets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Live Attenuated Vaccines for Pets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Live Attenuated Vaccines for Pets Sales by Region (2019-2024) & (K Units)
Table 18. Global Live Attenuated Vaccines for Pets Sales Market Share by Region (2019-2024)
Table 19. Global Live Attenuated Vaccines for Pets Sales by Region (2025-2030) & (K Units)
Table 20. Global Live Attenuated Vaccines for Pets Sales Market Share by Region (2025-2030)
Table 21. Global Live Attenuated Vaccines for Pets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Live Attenuated Vaccines for Pets Revenue Market Share by Region (2019-2024)
Table 23. Global Live Attenuated Vaccines for Pets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Live Attenuated Vaccines for Pets Revenue Market Share by Region (2025-2030)
Table 25. North America Live Attenuated Vaccines for Pets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Live Attenuated Vaccines for Pets Sales by Country (2019-2024) & (K Units)
Table 27. North America Live Attenuated Vaccines for Pets Sales by Country (2025-2030) & (K Units)
Table 28. North America Live Attenuated Vaccines for Pets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Live Attenuated Vaccines for Pets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Live Attenuated Vaccines for Pets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Live Attenuated Vaccines for Pets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Live Attenuated Vaccines for Pets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Live Attenuated Vaccines for Pets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Live Attenuated Vaccines for Pets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Live Attenuated Vaccines for Pets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Live Attenuated Vaccines for Pets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Live Attenuated Vaccines for Pets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Live Attenuated Vaccines for Pets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Live Attenuated Vaccines for Pets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Live Attenuated Vaccines for Pets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Live Attenuated Vaccines for Pets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Live Attenuated Vaccines for Pets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Live Attenuated Vaccines for Pets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Live Attenuated Vaccines for Pets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Live Attenuated Vaccines for Pets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Live Attenuated Vaccines for Pets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Live Attenuated Vaccines for Pets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Live Attenuated Vaccines for Pets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Live Attenuated Vaccines for Pets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Live Attenuated Vaccines for Pets Sales (K Units) by Type (2019-2024)
Table 51. Global Live Attenuated Vaccines for Pets Sales (K Units) by Type (2025-2030)
Table 52. Global Live Attenuated Vaccines for Pets Sales Market Share by Type (2019-2024)
Table 53. Global Live Attenuated Vaccines for Pets Sales Market Share by Type (2025-2030)
Table 54. Global Live Attenuated Vaccines for Pets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Live Attenuated Vaccines for Pets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Live Attenuated Vaccines for Pets Revenue Market Share by Type (2019-2024)
Table 57. Global Live Attenuated Vaccines for Pets Revenue Market Share by Type (2025-2030)
Table 58. Global Live Attenuated Vaccines for Pets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Live Attenuated Vaccines for Pets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Live Attenuated Vaccines for Pets Sales (K Units) by Application (2019-2024)
Table 61. Global Live Attenuated Vaccines for Pets Sales (K Units) by Application (2025-2030)
Table 62. Global Live Attenuated Vaccines for Pets Sales Market Share by Application (2019-2024)
Table 63. Global Live Attenuated Vaccines for Pets Sales Market Share by Application (2025-2030)
Table 64. Global Live Attenuated Vaccines for Pets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Live Attenuated Vaccines for Pets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Live Attenuated Vaccines for Pets Revenue Market Share by Application (2019-2024)
Table 67. Global Live Attenuated Vaccines for Pets Revenue Market Share by Application (2025-2030)
Table 68. Global Live Attenuated Vaccines for Pets Price (US$/Unit) by Application (2019-2024)
Table 69. Global Live Attenuated Vaccines for Pets Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Healthcare Corporation Information
Table 71. Bayer Healthcare Description and Business Overview
Table 72. Bayer Healthcare Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Healthcare Live Attenuated Vaccines for Pets Product
Table 74. Bayer Healthcare Recent Developments/Updates
Table 75. Vetoquinol S.A Corporation Information
Table 76. Vetoquinol S.A Description and Business Overview
Table 77. Vetoquinol S.A Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Vetoquinol S.A Live Attenuated Vaccines for Pets Product
Table 79. Vetoquinol S.A Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Live Attenuated Vaccines for Pets Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Corporation Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Ceva Live Attenuated Vaccines for Pets Product
Table 89. Ceva Recent Developments/Updates
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Eli Lilly Live Attenuated Vaccines for Pets Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Heska Corporation Information
Table 96. Heska Description and Business Overview
Table 97. Heska Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Heska Live Attenuated Vaccines for Pets Product
Table 99. Heska Recent Developments/Updates
Table 100. Merck Animal Health Corporation Information
Table 101. Merck Animal Health Description and Business Overview
Table 102. Merck Animal Health Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Merck Animal Health Live Attenuated Vaccines for Pets Product
Table 104. Merck Animal Health Recent Developments/Updates
Table 105. Merial (Sanofi) Corporation Information
Table 106. Merial (Sanofi) Description and Business Overview
Table 107. Merial (Sanofi) Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Merial (Sanofi) Live Attenuated Vaccines for Pets Product
Table 109. Merial (Sanofi) Recent Developments/Updates
Table 110. Virbac Corporation Information
Table 111. Virbac Description and Business Overview
Table 112. Virbac Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Virbac Live Attenuated Vaccines for Pets Product
Table 114. Virbac Recent Developments/Updates
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Pfizer Live Attenuated Vaccines for Pets Product
Table 119. Pfizer Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Live Attenuated Vaccines for Pets Distributors List
Table 123. Live Attenuated Vaccines for Pets Customers List
Table 124. Live Attenuated Vaccines for Pets Market Trends
Table 125. Live Attenuated Vaccines for Pets Market Drivers
Table 126. Live Attenuated Vaccines for Pets Market Challenges
Table 127. Live Attenuated Vaccines for Pets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Live Attenuated Vaccines for Pets
Figure 2. Global Live Attenuated Vaccines for Pets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Live Attenuated Vaccines for Pets Market Share by Type in 2023 & 2030
Figure 4. Virus Attenuated Vaccine Product Picture
Figure 5. Bacterial Attenuated Vaccine Product Picture
Figure 6. Global Live Attenuated Vaccines for Pets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Live Attenuated Vaccines for Pets Market Share by Application in 2023 & 2030
Figure 8. Dog
Figure 9. Cat
Figure 10. Dird
Figure 11. Others
Figure 12. Global Live Attenuated Vaccines for Pets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Live Attenuated Vaccines for Pets Market Size (2019-2030) & (US$ Million)
Figure 14. Global Live Attenuated Vaccines for Pets Sales (2019-2030) & (K Units)
Figure 15. Global Live Attenuated Vaccines for Pets Average Price (US$/Unit) & (2019-2030)
Figure 16. Live Attenuated Vaccines for Pets Report Years Considered
Figure 17. Live Attenuated Vaccines for Pets Sales Share by Manufacturers in 2023
Figure 18. Global Live Attenuated Vaccines for Pets Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Live Attenuated Vaccines for Pets Players: Market Share by Revenue in 2023
Figure 20. Live Attenuated Vaccines for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Live Attenuated Vaccines for Pets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Live Attenuated Vaccines for Pets Sales Market Share by Country (2019-2030)
Figure 23. North America Live Attenuated Vaccines for Pets Revenue Market Share by Country (2019-2030)
Figure 24. United States Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Live Attenuated Vaccines for Pets Sales Market Share by Country (2019-2030)
Figure 27. Europe Live Attenuated Vaccines for Pets Revenue Market Share by Country (2019-2030)
Figure 28. Germany Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Live Attenuated Vaccines for Pets Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Live Attenuated Vaccines for Pets Revenue Market Share by Region (2019-2030)
Figure 35. China Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Live Attenuated Vaccines for Pets Sales Market Share by Country (2019-2030)
Figure 45. Latin America Live Attenuated Vaccines for Pets Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Live Attenuated Vaccines for Pets Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Live Attenuated Vaccines for Pets Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Live Attenuated Vaccines for Pets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Live Attenuated Vaccines for Pets by Type (2019-2030)
Figure 55. Global Revenue Market Share of Live Attenuated Vaccines for Pets by Type (2019-2030)
Figure 56. Global Live Attenuated Vaccines for Pets Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Live Attenuated Vaccines for Pets by Application (2019-2030)
Figure 58. Global Revenue Market Share of Live Attenuated Vaccines for Pets by Application (2019-2030)
Figure 59. Global Live Attenuated Vaccines for Pets Price (US$/Unit) by Application (2019-2030)
Figure 60. Live Attenuated Vaccines for Pets Value Chain
Figure 61. Live Attenuated Vaccines for Pets Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
